Colorectal Cancer Clinical Trials in Los Angeles

Showing 241-244 of 244 trials

A Study of ABT-751 in Patients With Colorectal Cancer

NCT00073138

The purpose of the study is to determine if ABT-751 will decrease tumors, and determine how long the tumor shrinkage can be maintained in patients with colorectal cancer. Patients will receive ABT-751 by mouth daily for 21 days. Patients will be off drug for 7 days before starting the next cycle of drug.

Colorectal Cancer

Abbott40 participantsStarted Aug 2003

Los Angeles, California, United States • Santa Monica, California, United States • Chicago, Illinois, United States +3 more locations

UNKNOWNPhase 39.1 miles

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

NCT00337389

To compare the progression-free survival time (PFS) in patients treated with 5-FU modulated with CoFactor (plus bevacizumab) to 5-FU modulated with leucovorin (plus bevacizumab) in patients with Metastatic Colorectal Cancer.

Metastatic Colorectal CancerColon CancerRectal Cancer

Mast Therapeutics, Inc.1,200 participantsStarted May 2006

Florence, Alabama, United States • Anaheim, California, United States • Apple Valley, California, United States +44 more locations

A Study of ABT-751 in Patients With Colorectal Cancer

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Colorectal Cancer Trials in Other Cities

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Other Conditions in Los Angeles